TOPICAL LOCAL ANAESTHETIC SPRAY WITH VAPOCOOLANT VERSUS EMLA CREAM IN INFANTS DURING VACCINATIO
Not Applicable
Completed
- Registration Number
- CTRI/2021/05/033426
- Lead Sponsor
- DR AYUSH JAI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 228
Inclusion Criteria
All healthy infants of age group 9-11 weeks brought for immunization with 2nd dose of Liquid Pentavalent Vaccine
Exclusion Criteria
1)Infants with any painful lesion or condition
2)Infants receiving treatment with methaemoglobin-inducing agents
3)Infants on medications which can alter pain perception and response
4)Neurologically depressed infants due to any condition
5)Severe allergic reaction to a vaccine component or following a prior dose of a vaccine
6)History of reaction following application of topical anaesthetic agent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the pain reduction efficacy of the topical local anaesthetic spray with vapocoolant and EMLA cream during vaccination to childrenTimepoint: 0 minute, 1 minute and 5 minutes after injection
- Secondary Outcome Measures
Name Time Method ot ApplicableTimepoint: Not Applicable